CT
ABBV icon

Caldwell Trust’s AbbVie ABBV Stock Holding History

Caldwell Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81M Buy
27,070
+1,557
+6% +$335K 0.55% 46
2026
Q1 		$5.55M Buy
25,513
+1,064
+4% +$236K 0.5% 50
2025
Q4 		$5.59M Sell
24,449
-540
-2% -$123K 0.5% 51
2025
Q3 		$5.79M Sell
24,989
-121
-0.5% -$24.6K 0.54% 46
2025
Q2 		$4.66M Buy
25,110
+759
+3% +$141K 0.47% 51
2025
Q1 		$5.1M Buy
24,351
+244
+1% +$47.4K 0.55% 42
2024
Q4 		$4.28M Sell
24,107
-1,356
-5% -$249K 0.45% 52
2024
Q3 		$5.03M Buy
25,463
+538
+2% +$100K 0.53% 44
2024
Q2 		$4.28M Sell
24,925
-487
-2% -$80.7K 0.47% 47
2024
Q1 		$4.63M Sell
25,412
-334
-1% -$57.6K 0.54% 45
2023
Q4 		$3.99M Sell
25,746
-3,033
-11% -$442K 0.5% 49
2023
Q3 		$4.29M Sell
28,779
-2,699
-9% -$396K 0.59% 44
2023
Q2 		$4.24M Buy
31,478
+145
+0.5% +$21.3K 0.55% 45
2023
Q1 		$4.99M Sell
31,333
-170
-0.5% -$26K 0.69% 39
2022
Q4 		$5.09M Sell
31,503
-1,975
-6% -$303K 0.72% 40
2022
Q3 		$4.49M Sell
33,478
-967
-3% -$139K 0.67% 41
2022
Q2 		$5.28M Sell
34,445
-278
-0.8% -$42.5K 0.73% 39
2022
Q1 		$5.63M Sell
34,723
-74
-0.2% -$10.7K 0.67% 39
2021
Q4 		$4.71M Sell
34,797
-232
-0.7% -$27.4K 0.54% 45
2021
Q3 		$3.78M Buy
35,029
+1,350
+4% +$154K 0.48% 50
2021
Q2 		$3.79M Sell
33,679
-208
-0.6% -$23.4K 0.5% 48
2021
Q1 		$3.67M Buy
33,887
+299
+0.9% +$32K 0.51% 47
2020
Q4 		$3.6M Buy
33,588
+575
+2% +$55.3K 0.54% 46
2020
Q3 		$2.89M Sell
33,013
-864
-3% -$81.3K 0.48% 52
2020
Q2 		$3.33M Buy
33,877
+511
+2% +$45K 0.56% 51
2020
Q1 		$2.54M Sell
33,366
-2,412
-7% -$205K 0.48% 56
2019
Q4 		$3.17M Buy
+35,778
New +$2.97M 0.48% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Caldwell Trust's ABBV Position: Q2 2026 in Review

Caldwell Trust increased its AbbVie (ABBV) stake by 6.1% in Q2 2026, buying an estimated $335K and bringing the position to 27,070 shares worth $6.81M. The position accounts for 0.55% of the portfolio, ranked #46.

Caldwell Trust first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Caldwell Trust held 27,070 shares of AbbVie worth $6.81M as of Q2 2026.
  • Caldwell Trust bought 1,557 AbbVie shares in Q2 2026, an estimated $335K.
  • AbbVie made up 0.55% of Caldwell Trust's portfolio in Q2 2026, its #46 holding.
  • Caldwell Trust first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.